Confidence Ball May Start Rolling<br />By Rev Shark<br />RealMoney.com Contributor<br />12/20/2007 8:39 AM EST <br /><br /><br />Advances are made by those with at least a touch of irrational confidence in what they can do. <br />-- Joan L. Curcio<br /><br />Despite a steady flow of negative news and a rather gloomy mood, the market has done a nice job of recovery from several intraday dips the last couple of days. We haven't been able to generate any good upside traction, but we aren't selling off either. <br /><br />I said yesterday that the mood seemed particularly negative and that I believed that poor mood was supportive of at least a brief rally. Trying to invest based on opinions about the prevailing mood of the market is very difficult. There is a tendency for most investors to believe that their viewpoint is unique and therefore in the minority. In addition, the great mass of investors are neither strongly bullish or bearish. They have slight biases and uncertainties and can change their minds in a flash. <br /><br />That wishy-washy attitude of the bulk of investors underscores what this market is missing right now -- confidence. Even the folks who look for an end-of-year seasonal bounce don't seem to really trust it will be anything other than a temporary respite amid a steady flow of negative news. <br /><br />So what often drives the market is confidence that other folks share our feelings. We don't want to buy unless someone else is buying. We sit back and wait for indications that the buyers are stepping up, and only after we see some strength do we start to deploy our capital. <br /><br />Confidence feeds on itself, and once it starts it drives more confidence and more buying. That is really what momentum is all about and why it works. Once buyers start feeling more secure, they get the ball rolling and it continues to roll while others start feeling more secure about buying as well. <br /><br />We are a point now where the market could easily see some upside as a slight increase in confidence builds on itself. Once we get a few upticks, then buyers start thinking that end-of-year seasonality is finally kicking in and they become more secure about buying. That creates more strength, and before you know it, the folks on the sidelines are worried about being left behind, start jumping in and create more strength. <br /><br />So maybe the mood isn't overtly negative, but it has been lacking in buying confidence. That can shift very quickly, and as it does the upside looks promising. <br /><br />We have a good start this morning due to a number of strong earnings reports from the likes of Oracle (ORCL) , Nike (NKE) and FedEx (FDX) . Bear Stearns (BSC) is nearly flat on a poor report that seems to have been widely anticipated. <br /><br />Trading is going to start to slow as the holiday break beckons, and that may lead to increased volatility. Don't be shy about taking profits when you have them. <br /><br />No positions. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: VOL +20.6%, PIR +11.4%, MLHR +9.1% (also announces $200 mln share repurchase program), ORCL +6.5%, SCS +5.6% (also announces $250 mln share repurchase program), CAG +4.9%, ATVI +4.9%, ACN +4.7%, SMOD +3.7%, NKE +2.7%... M&A news: ECHO +108.1% (INTU to acquire ECHO for $17/share)... Other news: CNIC +20.4% (entered into a non-binding letter of interest with a third party), CGEN +18.6% (announces it has signed a collaborative discovery and license agreement with Roche), CNLG +17.6% (estimates 3-year backlog at over $4.5 mln, highest backlog of orders since the introduction of its new products), LOCM +8.0% (announces a strategic partnership with Citysearch), TSS +5.5% (will replace Synovus Financial (SNV) in the S&P 500 on 12/31), CRGN +4.9% (names Sean Cassidy as CFO), NVAX +4.7% (announces favorable interim results from Phase I/IIa Trial), CT +4.3% (announces $1.90/share special cash dividend), SLM +3.5% (says it and Citibank have amended the terms of the contracts so that there will be no trigger prices), LMC +2.9% (still checking), FDRY +2.8% (will replace Andrew (ANDW) in the S&P MidCap 400), RIMM +2.6% (still checking), ANPI +2.3% (authorized to begin Phase I trial of Multistem), NLY +2.2% (announces Q4 dividend 30% increase). Analyst upgrades: PBR +2.6% (upgraded to Buy at Citigroup), MA +2.2% (upgraded to Outperform at Bear Sterns), CLWR +2.1% (initiated with Buy at Stanford Financial).<br /><br />Allapoole avanevad:<br /><br />In reaction to weak earnings/guidance: RAD -14.6%, RUTH -13.8%, XING -12.5%, LDK -12.3% (also downgraded to Sell at Piper Jaffray), LEG -5.4%, PAYX -5.2%, HWAY -4.1%... Other news: MBI -18.6% (bond risk soars as co discloses CDO-squared exposure; credit-default swaps climb 110 bps to 590 bps- Bloomberg), ARRY -18.3% (announces phase 2 study shows no apparent difference in efficacy between AZD6244 and temozolomide for the primary endpoint), ALTU -17.0% (reacquires ALTU-238 global development and commercialization rights, also downgraded to Market Perform at Wachovia), PRST -15.5% (provides update regarding delayed quarterly filing of Form 10-Q for Q3 2007; also announced the SEC is conducting an informal inquiry), INGN -13.7% (plans to expand biomarker database in Phase 3 trials and file BLA and MAA for Advexin), FOLD -9.5% (announces positive results from phase 2 clinical trials of Amigal for Fabry Disease), NFI -8.2% (announces management changes), IDEV -7.8% (receives non-approvable letter from FDA for Valstar), GFI -3.3% (says overall attributable production for Q2 F2008 is expected to be down approximately 3.5% YoY), MICC -2.9% (still checking). Analyst downgrades: PCLN -2.9% (downgraded to Hold at Stifel).